Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renaissance SSA was the private label generics business of Renaissance Lakewood, specializing in the development and manufacture of generic pharmaceuticals—primarily nasal sprays and sterile injectables. In 2018, this division was divested through multiple transactions. The parent company now operates solely as a CDMO with no internal generic drug programs.[1]
As such, there are no current clinical results or pipeline programs under the name "Renaissance SSA."
When active, it manufactured FDA-approved nasal spray drugs among other products.[2]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renaissance SSA.